Grants and Contributions:
Title:
Implementation of ex vivo lung perfusion into an automated mobile system
Agreement Number:
977715
Agreement Value:
$344,000.00
Agreement Date:
Jul 1, 2021 - Jan 31, 2023
Description:
A mobile and automated system will be created to implement ex vivo lung perfusion, a technique used to assess lungs in preparation for lung transplant.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Mississauga, Ontario, CA L5L 5Y7
Reference Number:
172-2021-2022-Q2-977715
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
717995286
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 276 days. The total amended value is 94,000 dollars.
Amendment Date
Mar 11, 2022
Recipient's Legal Name:
Traferox Technologies Inc
Federal Riding Name:
Mississauga--Erin Mills
Federal Riding Number:
35060
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
339110
Amendments: